Guyer Charles Greg (CIK 1811096) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell BMRN (1,693 shares), Sell BMRN (9,109 shares), Buy BMRN (14,990 shares), Sell BMRN (16,486 shares), Buy BMRN (6,176 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 1,693 | $94,893 |
| 2026-03-17 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 9,109 | $532,968 |
| 2026-03-17 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 14,990 | $0 |
| 2026-03-12 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 16,486 | $996,744 |
| 2026-02-26 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 6,176 | $0 |
| 2026-02-26 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 6,675 | $0 |
| 2026-02-26 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 2,371 | $0 |
| 2026-02-13 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 317 | $17,162 |
| 2026-02-13 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 62 | $2,823 |
| 2025-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 20,127 | $1.4M |
| 2025-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 13,310 | $0 |
| 2025-03-07 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 7,034 | $501,384 |
| 2025-03-04 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Sell | 4,287 | $305,063 |
| 2025-02-27 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 11,040 | $0 |
| 2025-02-27 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 9,660 | $0 |
| 2025-02-27 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Technical Officer | Buy | 9,367 | $0 |
Source: SEC Form 4 filings · as of 2026-03-19